Human parotid secretory protein is a lipopolysaccharide-binding protein: identification of an anti-inflammatory peptide domain

被引:34
|
作者
Abdolhosseini, Mahsa [1 ]
Sotsky, Julie B. [2 ]
Shelar, Anuradha P. [2 ]
Joyce, Paul B. M. [3 ,4 ]
Gorr, Sven-Ulrik [1 ,2 ]
机构
[1] Univ Minnesota, Sch Dent, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA
[2] Univ Louisville, Sch Dent, Oral Hlth & Syst Dis Res Grp, Dept Periodont Endodont & Dent Hyg, Louisville, KY 40292 USA
[3] Concordia Univ, Dept Chem & Biochem, Montreal, PQ H3G 1M8, Canada
[4] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ H3G 1M8, Canada
关键词
Saliva; Endotoxin; SPLUNC2; C20orf70; Antimicrobial peptide; Lipopolysaccharide-binding protein; SPLUNC1; PROTEIN; SALIVARY PROTEIN; GLAND PROTEIN; HOST-DEFENSE; PLUNC; MEMBERS; EXPRESSION; EPITHELIA; CLONING; DESIGN;
D O I
10.1007/s11010-011-0991-2
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Parotid secretory protein (PSP) (C20orf70) is a salivary protein of unknown function. The protein belongs to the palate, lung, and nasal epithelium clone (PLUNC) family of mucosal secretory proteins that are predicted to be structurally similar to lipid-binding and host-defense proteins including bactericidal/permeability-increasing protein and lipopolysaccharide-binding protein. However, the PLUNC proteins exhibit significant sequence variation and different biological functions have been proposed for different family members. This study tested the functional implications of the proposed similarity of PSP to the acute phase protein lipopolysaccharide-binding protein (LBP). PSP was identified in human saliva and was soluble in 70% ethanol, as shown for other PLUNC proteins. PSP binds lipopolysaccharide and can be eluted by non-ionic detergent, but not by urea or high salt. A synthetic PSP peptide, GL13NH2, which corresponds to a lipopolysaccharide-inhibiting peptide from LBP, inhibited the binding of lipopolysaccharide to both PSP and lipopolysaccharide-binding protein. Peptides from other regions of PSP and the control peptide polymyxin B showed no effect on the binding of PSP to lipopolysaccharide. GL13NH2 also inhibited lipopolysaccharide-stimulated secretion of tumor necrosis factor from macrophages. The other PSP peptides had no effect in this assay. PSP peptides had no or only minor effect on macrophage cell viability. These results indicate that PSP is a lipopolysaccharide-binding protein that is functionally related to LBP, as suggested by their predicted structural similarities.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [21] Serum lipopolysaccharide-binding protein as a marker of atherosclerosis
    Serrano, Marta
    Maria Moreno-Navarrete, Jose
    Puig, Josep
    Moreno, Maria
    Guerra, Ester
    Ortega, Francisco
    Xifra, Gemma
    Ricart, Wifredo
    Manuel Fernandez-Real, Jose
    ATHEROSCLEROSIS, 2013, 230 (02) : 223 - 227
  • [22] HUMAN CAP18 - A NOVEL ANTIMICROBIAL LIPOPOLYSACCHARIDE-BINDING PROTEIN
    LARRICK, JW
    HIRATA, M
    BALINT, RF
    LEE, J
    ZHONG, J
    WRIGHT, SC
    INFECTION AND IMMUNITY, 1995, 63 (04) : 1291 - 1297
  • [23] Production of lipopolysaccharide-binding protein by human and mouse keratinocyte cell lines
    Matheis, P
    Jang, H
    Reardon, CL
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) : 324 - 324
  • [24] PURIFICATION AND CHARACTERIZATION OF MURINE LIPOPOLYSACCHARIDE-BINDING PROTEIN
    GALLAY, P
    CARREL, S
    GLAUSER, MP
    BARRAS, C
    ULEVITCH, RJ
    TOBIAS, PS
    BAUMGARTNER, JD
    HEUMANN, D
    INFECTION AND IMMUNITY, 1993, 61 (02) : 378 - 383
  • [25] Preparation and characterization of truncated human lipopolysaccharide-binding protein in Escherichia coli
    Kohara, Jun
    Tsuneyoshi, Naoko
    Gauchat, Jean-Francois
    Kimoto, Masao
    Fukudome, Kenji
    PROTEIN EXPRESSION AND PURIFICATION, 2006, 49 (02) : 276 - 283
  • [26] Neutrophils responded to immobilized lipopolysaccharide in the absence of lipopolysaccharide-binding protein
    Nakatomi, K
    Aida, Y
    Kusumoto, K
    Pabst, MJ
    Maeda, K
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 64 (02) : 177 - 184
  • [27] HUMAN LIPOPOLYSACCHARIDE-BINDING PROTEIN POTENTIATES BACTERICIDAL ACTIVITY OF HUMAN BACTERICIDAL PERMEABILITY-INCREASING PROTEIN
    HORWITZ, AH
    WILLIAMS, RE
    NOWAKOWSKI, G
    INFECTION AND IMMUNITY, 1995, 63 (02) : 522 - 527
  • [28] IDENTIFICATION AND CHARACTERIZATION OF A PRIMARY ANTIBACTERIAL DOMAIN IN CAP18, A LIPOPOLYSACCHARIDE-BINDING PROTEIN FROM RABBIT LEUKOCYTES
    TOSSI, A
    SCOCCHI, M
    SKERLAVAJ, B
    GENNARO, R
    FEBS LETTERS, 1994, 339 (1-2) : 108 - 112
  • [29] COMPETITION BETWEEN BACTERICIDAL PERMEABILITY-INCREASING PROTEIN AND LIPOPOLYSACCHARIDE-BINDING PROTEIN FOR LIPOPOLYSACCHARIDE BINDING TO MONOCYTES
    HEUMANN, D
    GALLAY, P
    BETZCORRADIN, S
    BARRAS, C
    BAUMGARTNER, JD
    GLAUSER, MP
    JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (06): : 1351 - 1357
  • [30] Purification of lipopolysaccharide-binding protein from bovine serum
    Bochsler, PN
    Yang, ZG
    Murphy, CL
    Carroll, RC
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 51 (3-4) : 303 - 314